Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Modeling the heterogeneity of multiple sclerosis in animals.
Natalizumab in relapsing-remitting multiple sclerosis.
Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis.
Daily hassles reported by Dutch multiple sclerosis patients.
Neurological disability and its association with walking impairment in multiple sclerosis: brief review.
Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura and hemolytic uremic syndrome reports with SC interferon beta-1a.
Efficacy and safety of alemtuzumab in patients with relapsing-remitting multiple sclerosis who relapsed on prior therapy: Four-year follow-up of the Care-MS II study.
Alemtuzumab: A new therapy for active relapsing-remitting multiple sclerosis.
CD44 is required for the migration of transplanted oligodendrocyte progenitor cells to focal inflammatory demyelinating lesions in the spinal cord.
T cell vaccination in multiple sclerosis: results of a preliminary study.
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.
MR imaging findings of the corpus callosum region in the differentiation between multiple sclerosis and neuromyelitis optica.
Differences in Diffusion Tensor Imaging-Derived Metrics in the Corpus Callosum of Patients With Multiple Sclerosis Without and With Gadolinium-Enhancing Cerebral Lesions.
Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex.
The nocebo effect: A clinicians guide.
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient.
The best basic science paper in multiple sclerosis in 2014: Important role for the choroid plexus in the central nervous system entry of leukocytes.
Alteration of CD1 expression in multiple sclerosis.
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection.
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.
Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review.
Multiple Sclerosis and Venous Abnormalities: Medicine in the Age of Social Media.
Optic Neuritis Probably Induced by Isotretinoin.
Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
Biologic therapies: lessons from multiple sclerosis.

Pages